Valuation : CellaVision AB

Market Cap 3.84B 400M 344M 324M 295M 552M 38.05B 555M 1.48B 19.39B 1.5B 1.47B 61.41B P/E 2026 *
27.8x
P/E 2027 * 22.2x
Enterprise Value 3.65B 380M 327M 308M 281M 525M 36.19B 527M 1.41B 18.44B 1.43B 1.4B 58.42B EV / Sales 2026 *
4.71x
EV / Sales 2027 * 4.16x
Free-Float
81.06%
Yield 2026 *
1.7%
Yield 2027 * 1.93%
1 day-0.12%
1 week-2.19%
Current month-3.25%
1 month+5.64%
3 months+25.39%
6 months+5.50%
Current year+2.42%
1 week 157.6
Extreme 157.6
164.4
1 month 150.2
Extreme 150.2
170.4
Current year 117.6
Extreme 117.6
170.4
1 year 117.6
Extreme 117.6
192.2
3 years 117.6
Extreme 117.6
302
5 years 117.6
Extreme 117.6
462.6
10 years 70.75
Extreme 70.75
503.5
Manager TitleAgeSince
Chief Executive Officer - 04/06/2026
Director of Finance/CFO 46 01/09/2025
Investor Relations Contact - -
Director TitleAgeSince
Director/Board Member 61 -
Director/Board Member 62 03/05/2018
Chairman 64 28/04/2021
Date Insider Type Main position Quantity % Market Cap. Importance
02/09/26 Free 100,000 0.4193%
28/04/26 Don

Founder

76,434 0.3205%
28/04/26 Buy

Founder

20,000 0.0839%
Change 5-day change 1-year change 3-year change Capi.($)
-0.74%-2.19%-7.79%-10.85% 404M
-0.55%-4.21%+21.28%-32.15% 17.12B
-2.34%+6.87%-32.09%+54.17% 1.75B
-5.53%-9.39%-55.74%-83.04% 918M
-1.27%-4.67%-23.85%+20.80% 918M
+0.05%+0.16%+59.62%-2.94% 779M
-1.94%-3.55%-34.99%-47.28% 679M
-2.30%-1.25%-42.24%-44.83% 619M
+2.90%-21.50%-46.08%-42.43% 420M
-1.22%-6.20%+71.50%+49.77% 405M
Average -1.31%-4.12%-9.04%-13.88% 2.4B
Weighted average by Cap. -0.97%-3.18%+9.92%-24.03%

Financials

2026 *2027 *
Net sales 775M 80.72M 69.46M 65.4M 59.59M 111M 7.68B 112M 300M 3.91B 303M 297M 12.4B 870M 90.6M 77.96M 73.41M 66.89M 125M 8.62B 126M 336M 4.39B 340M 333M 13.91B
Net income 139M 14.48M 12.46M 11.73M 10.69M 20M 1.38B 20.08M 53.73M 702M 54.36M 53.18M 2.22B 174M 18.16M 15.63M 14.71M 13.41M 25.08M 1.73B 25.18M 67.39M 880M 68.19M 66.7M 2.79B
Net Debt -188M -19.53M -16.8M -15.82M -14.42M -26.97M -1.86B -27.08M -72.47M -947M -73.32M -71.73M -3B -222M -23.11M -19.88M -18.72M -17.06M -31.92M -2.2B -32.04M -85.76M -1.12B -86.77M -84.88M -3.55B
Logo CellaVision AB
CellaVision AB is a Sweden-based company active in the medical technology sector. The Company develops and sells digital solutions for medical microscopy, as well as products enabling blood cell analysis and morphology diagnosis. CellaVision AB’s product portfolio consists of analyzers for automated medical microscopy analysis and software applications designed for remote access, competency testing and education. The analyzers include such brands as CellaVision DM96 and CellaVision DM1200, whereas the software applications are divided into CellaVision Body Fluid Application, CellaVision Remote Review Software and CellaVision Competency Software, among others. The Company operates four subsidiaries, based in Sweden, Canada, the United States and Japan. In June 2014, CellaVision AB acquired technology platform from Clear Lake Medical Foundation.
Employees
251
Date Price Change Volume
09/09/26 SEK 161.00 -0.74% 36,539
08/09/26 SEK 162.20 +0.12% 20,666
07/09/26 SEK 162.00 +1.00% 33,231
04/09/26 SEK 160.40 -1.35% 27,807
03/09/26 SEK 162.60 -0.12% 29,805
Trader
Investor
Global
Quality
ESG MSCI
AAA
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
3
Last Close Price
162.20SEK
Average target price
175.67SEK
Spread / Average Target
+8.30%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. CEVI Stock
40% Discount: Identify Tomorrow's Best Investments With The Best Subscriber-Only Tools!
d
:
:
SEIZE THE OFFER!